BNGO Earnings Bionano Genomics, Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–24 of 24
| Q2 2026 | 2026-06-30 | -1.40 | 2026-08-10 | 10-Q |
| Q1 2026 | 2026-03-31 | -0.76 | 2026-05-13 | 10-Q |
| FY 2025 | 2025-12-31 | -4.85 | 2026-03-23 | 10-K |
| Q3 2025 | 2025-09-30 | -4.82 | 2025-11-13 | 10-Q |
| Q2 2026 | 2025-06-30 | -3.24 | 2026-08-10 | 10-Q |
| Q1 2026 | 2025-03-31 | -1.15 | 2026-05-13 | 10-Q |
| FY 2025 | 2024-12-31 | -88.13 | 2026-03-23 | 10-K |
| Q3 2025 | 2024-09-30 | -80.18 | 2025-11-13 | 10-Q |
| Q2 2025 | 2024-06-30 | -47.50 | 2025-08-14 | 10-Q |
| Q1 2025 | 2024-03-31 | -35.75 | 2025-05-14 | 10-Q |
| FY 2024 | 2023-12-31 | -408.60 | 2025-03-31 | 10-K |
| Q3 2024 | 2023-09-30 | -5.85 | 2024-11-14 | 10-Q |
| Q2 2024 | 2023-06-30 | -2.46 | 2024-08-07 | 10-Q |
| Q1 2024 | 2023-03-31 | -1.23 | 2024-05-08 | 10-Q |
| FY 2023 | 2022-12-31 | -4.58 | 2024-03-05 | 10-K |
| Q3 2023 | 2022-09-30 | -3.28 | 2023-11-08 | 10-Q |
| Q2 2023 | 2022-06-30 | -2.18 | 2023-08-09 | 10-Q |
| Q1 2023 | 2022-03-31 | -0.11 | 2023-05-09 | 10-Q |
| FY 2022 | 2021-12-31 | -0.26 | 2023-03-09 | 10-K |
| Q3 2022 | 2021-09-30 | -0.18 | 2022-11-03 | 10-Q |
| Q2 2022 | 2021-06-30 | -0.11 | 2022-08-04 | 10-Q |
| Q1 2022 | 2021-03-31 | -0.04 | 2022-05-05 | 10-Q |
| Q3 2021 | 2020-09-30 | -0.34 | 2021-11-04 | 10-Q |
| Q2 2021 | 2020-06-30 | -0.29 | 2021-08-04 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.